Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm

Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked eosinophilia, the clinical presentation varies significantly and can even manifest a...

Full description

Saved in:
Bibliographic Details
Main Authors: Coen J. Lap, Samah Nassereddine, Min-Ling Liu, Victor E. Nava, Anita Aggarwal
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2021/2348977
Tags: Add Tag
No Tags, Be the first to tag this record!